BioAge Labs, Inc. (BIOA)
5.34
-0.20
(-3.61%)
USD |
NASDAQ |
Nov 06, 16:00
5.33
-0.01
(-0.19%)
After-Hours: 20:00
BioAge Labs Research and Development Expense (Annual) : 73.97M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 73.97M |
| December 31, 2024 | 59.04M |
| Date | Value |
|---|---|
| December 31, 2023 | 33.89M |
| December 31, 2022 | 30.52M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alumis, Inc. | 377.10M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |
| Johnson & Johnson | 14.83B |